Skip to main content

More Filters

We narrowed to 336 results for: LIS

Showing: 91 - 100 of 336 results
  1. pAAV-Ef1a-DIO-PPO-Venus (AAV9)

    Viral Prep
    #139505-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO-PPO-Venus (#139505). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO-PPO-Venus plasmid DNA. EF1a-driven, Cre-dependent expression of Venus-tagged parapinopsin for spatiotemporal control of inhibitory GPCR signaling cascades. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    Venus (Cre-dependent)
    Available Since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-Ef1a-DIO-PPO-Venus (AAV8)

    Viral Prep
    #139505-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-Ef1a-DIO-PPO-Venus (#139505). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO-PPO-Venus plasmid DNA. EF1a-driven, Cre-dependent expression of Venus-tagged parapinopsin for spatiotemporal control of inhibitory GPCR signaling cascades. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    Venus (Cre-dependent)
    Available Since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only
  3. AAV phSyn1(S)-DreO-bGHpA (AAV Retrograde)

    Viral Prep
    #50363-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from AAV phSyn1(S)-DreO-bGHpA (#50363). In addition to the viral particles, you will also receive purified AAV phSyn1(S)-DreO-bGHpA plasmid DNA. hSyn-driven Dre recombinase expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    Aug. 18, 2020
    Availability
    Academic Institutions and Nonprofits only
  4. pGP-AAV-CAG-FLEX-jGCaMP8m-WPRE (AAV Retrograde)

    Viral Prep
    #162381-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pGP-AAV-CAG-FLEX-jGCaMP8m-WPRE (#162381). In addition to the viral particles, you will also receive purified pGP-AAV-CAG-FLEX-jGCaMP8m-WPRE plasmid DNA. CAG-driven, Cre-dependent expression of calcium sensor GCaMP8m (faster, more sensitive). These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only
  5. pGP-AAV-CAG-FLEX-jGCaMP8f-WPRE (AAV Retrograde)

    Viral Prep
    #162382-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pGP-AAV-CAG-FLEX-jGCaMP8f-WPRE (#162382). In addition to the viral particles, you will also receive purified pGP-AAV-CAG-FLEX-jGCaMP8f-WPRE plasmid DNA. CAG-driven, Cre-dependent expression of the ultrafast calcium sensor GCaMP8f. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Sept. 13, 2021
    Availability
    Academic Institutions and Nonprofits only
  6. AAV pCAG-FLEX-EGFP-WPRE (AAV9)

    Viral Prep
    #51502-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EGFP (Cre-dependent)
    Available Since
    March 8, 2018
    Availability
    Academic Institutions and Nonprofits only
  7. AAV pCAG-FLEX-EGFP-WPRE (AAV1)

    Viral Prep
    #51502-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EGFP (Cre-dependent)
    Available Since
    March 7, 2018
    Availability
    Academic Institutions and Nonprofits only
  8. AAV pCAG-FLEX-EGFP-WPRE (AAV5)

    Viral Prep
    #51502-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EGFP (Cre-dependent)
    Available Since
    Oct. 3, 2019
    Availability
    Academic Institutions and Nonprofits only
  9. AAV pCAG-FLEX-EGFP-WPRE (AAV2)

    Viral Prep
    #51502-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EGFP (Cre-dependent)
    Available Since
    March 7, 2018
    Availability
    Academic Institutions and Nonprofits only
  10. AAV pCAG-FLEX-EGFP-WPRE (AAV8)

    Viral Prep
    #51502-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre-dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    EGFP (Cre-dependent)
    Available Since
    Jan. 26, 2021
    Availability
    Academic Institutions and Nonprofits only
Showing: 91 - 100 of 336 results